What Is BPC-157?

Overview

BPC-157 — short for "body protection compound 157" — is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to a fragment of a larger protective protein originally identified in gastric juice, which is where its reputation for stability in an acidic environment comes from. In the research literature it appears most often in animal and cell-culture studies of wound healing, gastrointestinal injury and soft-tissue regeneration, where investigators are interested in how a single small peptide appears to influence so many different repair pathways at once.

How BPC-157 Works

Unlike receptor-selective peptides, BPC-157 has no single confirmed receptor or mechanism. The studies instead describe a cluster of overlapping pathways: promotion of new blood-vessel formation (angiogenesis) and modulation of vascular endothelial growth factor, signalling through the nitric oxide system, and effects on fibroblast migration, cell survival under stress, and the FAK–paxillin pathway that governs how cells anchor and move during tissue repair. The recurring theme across these models is cytoprotection — shielding cells from damage and accelerating the rebuilding of injured tissue. It is worth stressing that a plausible biological mechanism explains why a compound is investigated; it does not demonstrate that the compound produces a meaningful outcome in people.

What the Research Explores

• Gastrointestinal injury models, including ulcers, colitis, fistula formation and NSAID-induced damage.
• Tendon and ligament repair, studied in rat Achilles-tendon transection and isolated fibroblast cultures.
• General wound-healing dynamics, including bleeding, thrombosis and tissue-injury recovery.
• Angiogenesis and the vascular contribution to muscle and tendon healing.
• Small clinical pilot work, such as a retrospective intra-articular knee-pain report and a pilot study in interstitial cystitis.

Forms & Handling

BPC-157 is typically supplied as a lyophilized (freeze-dried) powder, commonly in 10 mg, 20 mg or 30 mg vials. For laboratory work it is reconstituted with bacteriostatic or sterile water, then kept refrigerated once in solution; the sealed lyophilized vial is stored frozen or cold and protected from light to preserve peptide integrity. See the dosing protocols below for the reconstitution math expressed in insulin-syringe units.

Safety & Research Notes

BPC-157 is an investigational research compound with no approved human or veterinary indication and no established safety profile for administration. Pre-clinical pharmacokinetic and toxicology work exists in rats and dogs, and a small number of early-phase human trials have been registered, but the evidence base remains limited and largely laboratory-bound. It is also a prohibited substance under anti-doping rules. Everything described here is mechanistic and historical background, not a usage recommendation.

References

Related Protocols